ConforMIS News

Disclaimer: This part of our website contains archival information which should not be considered current and may no longer be accurate.

Archive for 2015

  • Monday, 8/3/15

    ConforMIS Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction

    ConforMIS customized knee replacement

    ConforMIS’s customized iTotal CR knee replacements demonstrate superior functional outcomes compared to off-the-shelf knee replacements in multiple studies Bedford, Mass. – August 3, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015 Pan Pacific International Congress for Joint Reconstruction (ICJR). In an ongoing, blinded, US multicenter study, the investigators reported…

    Read more »
  • Tuesday, 7/7/15

    ConforMIS Closes Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – July 7, 2015 – ConforMIS, Inc. (NASDAQ: CFMS) announced today the closing of its initial public offering of 10,350,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts, including 1,350,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS CEO: Getting A Knee Up (Mad Money, CNBC)

    Philipp Lang ConforMIS CEO on CNBC Mad Money

    Click here to read the full show recap on TheStreet.com ConforMIS is not responsible for the contents or reliability of any third-party materials accessible on ConforMIS’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or…

    Read more »
  • Wednesday, 7/1/15

    ConforMIS Announces Pricing of Its Initial Public Offering

    ConforMIS customized knee replacement

    Bedford, Mass. – June 30, 2015 – ConforMIS, Inc. announced today the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by ConforMIS. In addition, ConforMIS has granted the underwriters an option to…

    Read more »
  • Friday, 4/17/15

    ConforMIS Announces Settlement of Patent Infringement Lawsuits

    ConforMIS customized knee replacement

    Licenses Expand the Footprint of ConforMIS’ Patented Patient-Specific Instrumentation Technology Bedford, Mass. – April 17, 2015 – ConforMIS, Inc., a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell customized joint replacement implants, today announced that it has entered into license agreements with each of Wright Medical Technology, Inc. (“Wright”) and…

    Read more »
  • Tuesday, 3/24/15

    ConforMIS Announces Latest Generation iTotal Customized Total Knee Replacement Implant System

    ConforMIS customized knee replacement

    Upgrades include improvements to customized implants and iJig patient-specific instruments Bedford, Mass. – March 24, 2015 – ConforMIS, Inc., a medical technology company providing customized total knee replacement implants for patients, today announced a new generation of the company’s iTotal® CR (cruciate-retaining) total knee replacement. The new generation iTotal CR was designed to improve procedural efficiency by further…

    Read more »
  • Tuesday, 1/6/15

    ConforMIS to Present at J.P. Morgan 33rd Annual Healthcare Conference

    ConforMIS customized knee replacement

    Bedford, Mass. – January 5, 2015 – ConforMIS, Inc., a medical device company providing the only truly customized knee replacement implant systems, today announced Philipp Lang, MD, MBA, Chairman and CEO of ConforMIS, will present at the 33rd Annual J.P. Morgan Healthcare Conference. Dr. Lang will highlight advantages of customized implants to patients, surgeons, hospitals and payers beginning…

    Read more »